PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) as a Future Migraine Treatment Target

In this episode, leading researcher Dr. Messoud Ashina explains what PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) is and how it is involved in migraine pathophysiology. He also talks about how it differs from CGRP and why it could be a promising target for migraine and other headache disorders.
Read the transcript at www.migrainedisorders.org/podcast/s6ep5-pacap-as-a-future-migraine-target
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.